Freya Pharma Solutions
Freya Pharma launches phase 2 study of therapy for female sexual dysfunction
August 5, 2025Research and Development Female Sexual Interest/Arousal Disorder (FSIAD), Freya Pharma Solutions, Genito-Urinary system, sexual health
Freya Pharma Solutions has announced the initiation of a phase 2 study evaluating its Lybrido to treat female sexual interest/arousal …
